Invivyd to Host Conference Call to Announce Results from Interim Analysis of Phase 3 DECLARATION Trial
MARKET IMPACTNEUTRAL✦ News Impact agent estimateTone: neutralClinical trial results announcement that can move the company's share price.AI-generated summary
✦ IN BRIEF · AIAI-generated summary
- 01Invivyd will hold a conference call to announce interim analysis results.
- 02The trial is the Phase 3 DECLARATION study.
- 03The investor call is set for 8:30 a.m. ET on November 23, 2026.